Loading provider…
Loading provider…
Surgical Oncology Physician in Loma Linda, CA
NPI: 1467482554Primary Practice Location
LOMA LINDA UNIVERSITY MEDICAL CENTER
11234 Anderson St, Loma Linda, CA
Primary Employer
Faculty Physicians and Surgeons of Llusm
lluh.org
HQ Phone
Get M.D. Mark's Phone Numberphone_androidMobile
Get M.D. Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1996 - 2026
MD State Medical License
1994 - 1997

American Board of Surgery
Surgery
Loma Linda University School Of Medicine
medicine.llu.edu
Medical School
Until 1992
David Geffen School of Medicine at UCLA
medschool.ucla.edu
PhD • Biochemistry
1985 - 1990
Memorial Sloan Kettering Cancer Center
Fellowship • Complex General Surgical Oncology
1998 - 2000
Loma Linda University Health Education Consortium
Residency • Surgery
1996 - 1998
Residency • Surgery
1992 - 1994
National Institutes of Health Clinical Center
Fellowship • Abdominal Transplant Surgery
1994 - 1996
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 18 | 33 |
Authors: Patrick Hwu
Journal: Gene Ther
Influence of Student Loan Debt on General Surgery Resident Career and Lifestyle Decision-Making.
Authors: Christian De Virgilio, Kelsey Gray, Kristine Calhoun, Timothy Donahue, Farin Amersi, Edgardo Salcedo, Angela Neville, Marc Melcher, Mary Wolfe, Daniel Dent, Brian Smith, Jeffrey Gauvin
Journal: J Am Coll Surg
Publication Date: 2019-11-26
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Fludeoxyglucose F-18, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, PROCEDURE: Computed Tomography, RADIATION: Stereotactic Body Radiation Therapy
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, BIOLOGICAL: Pembrolizumab, PROCEDURE: Biospecimen Collection, PROCEDURE: Therapeutic Conventional Surgery, PROCEDURE: Computed Tomography
Lead Sponsor: RenovoRx
Intervention / Treatment: DRUG: Gemcitabine, DRUG: nab-paclitaxel, DEVICE: RenovoCath